Clinical Trials · NCT00505817

GnRH Agonist and Antagonists in an Oocyte Donation Program

CompletedPhase 4Gonadorelin (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
Instituto Valenciano de Infertilidad, IVI VALENCIA
Enrollment
0
Start date
Not specified
Locations
1 site, Spain
Primary endpoint
Study in Effect of Two Protocols of Ovarian Stimulation on Oocyte Quality
View Gonadorelin compound reference